10.1074/jbc.M503075200 Veeravalli K, Boyd D, Iverson BL, Beckwith J, Georgiou G: Laboratory evolution of glutathione biosynthesis reveals natural compensatory pathways
Dieckmann, A., Kriebel, M., Andriambeloson, E., Ziegler, D
These findings suggest that the observed trend toward benefit is unlikely to be driven by a single biased study, although the overall certainty of evidence remains limited by imprecision and heterogeneity
Frandsens clinical approach integrates functional laboratory assessment, toxin-binding strategies, immune modulation, mitochondrial support, and individualized detoxification protocols
Importantly, there were no cardiovascular adverse events, no clinically significant changes in blood pressure or heart rate, no alterations in thyroid function, no immunogenicity with no anti-AOD-9604 antibodies detected, and no signs of tolerance or receptor desensitization